Targeting presynaptic H3 heteroreceptor in nucleus accumbens to improve anxiety and obsessive-compulsive-like behaviors

Proc Natl Acad Sci U S A. 2020 Dec 15;117(50):32155-32164. doi: 10.1073/pnas.2008456117. Epub 2020 Nov 30.

Abstract

Anxiety commonly co-occurs with obsessive-compulsive disorder (OCD). Both of them are closely related to stress. However, the shared neurobiological substrates and therapeutic targets remain unclear. Here we report an amelioration of both anxiety and OCD via the histamine presynaptic H3 heteroreceptor on glutamatergic afferent terminals from the prelimbic prefrontal cortex (PrL) to the nucleus accumbens (NAc) core, a vital node in the limbic loop. The NAc core receives direct hypothalamic histaminergic projections, and optogenetic activation of hypothalamic NAc core histaminergic afferents selectively suppresses glutamatergic rather than GABAergic synaptic transmission in the NAc core via the H3 receptor and thus produces an anxiolytic effect and improves anxiety- and obsessive-compulsive-like behaviors induced by restraint stress. Although the H3 receptor is expressed in glutamatergic afferent terminals from the PrL, basolateral amygdala (BLA), and ventral hippocampus (vHipp), rather than the thalamus, only the PrL- and not BLA- and vHipp-NAc core glutamatergic pathways among the glutamatergic afferent inputs to the NAc core is responsible for co-occurrence of anxiety- and obsessive-compulsive-like behaviors. Furthermore, activation of the H3 receptor ameliorates anxiety and obsessive-compulsive-like behaviors induced by optogenetic excitation of the PrL-NAc glutamatergic afferents. These results demonstrate a common mechanism regulating anxiety- and obsessive-compulsive-like behaviors and provide insight into the clinical treatment strategy for OCD with comorbid anxiety by targeting the histamine H3 receptor in the NAc core.

Keywords: OCD; anxiety; histamine H3 receptor; nucleus accumbens; prelimbic prefrontal cortex.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Afferent Pathways / drug effects
  • Afferent Pathways / physiopathology
  • Animals
  • Anxiety Disorders / drug therapy*
  • Anxiety Disorders / etiology
  • Anxiety Disorders / physiopathology
  • Anxiety Disorders / psychology
  • Disease Models, Animal
  • Glutamates / metabolism
  • Histamine / metabolism
  • Histamine Agonists / administration & dosage*
  • Histamine H3 Antagonists / administration & dosage
  • Humans
  • Hypothalamic Area, Lateral / drug effects
  • Hypothalamic Area, Lateral / physiopathology
  • Male
  • Neurons / drug effects
  • Neurons / metabolism
  • Nucleus Accumbens / cytology
  • Nucleus Accumbens / drug effects
  • Nucleus Accumbens / physiopathology*
  • Obsessive-Compulsive Disorder / drug therapy*
  • Obsessive-Compulsive Disorder / etiology
  • Obsessive-Compulsive Disorder / physiopathology
  • Obsessive-Compulsive Disorder / psychology
  • Optogenetics
  • Patch-Clamp Techniques
  • Prefrontal Cortex / cytology
  • Prefrontal Cortex / drug effects
  • Prefrontal Cortex / physiopathology
  • Presynaptic Terminals / drug effects
  • Presynaptic Terminals / metabolism
  • Rats
  • Rats, Transgenic
  • Receptors, Histamine H3 / metabolism*
  • Stereotaxic Techniques
  • Stress, Psychological / complications
  • Stress, Psychological / psychology
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology

Substances

  • Glutamates
  • Histamine Agonists
  • Histamine H3 Antagonists
  • Receptors, Histamine H3
  • Histamine